Health IT Analytics April 9, 2021
A blood test made up of RNA biomarkers can tailor medication choices to individual patients with mood disorders, leading to precision medicine treatments.
A new blood test may reveal the biological basis of mood disorders and offer precision medicine approaches to treatment, according to a study published in Molecular Psychiatry.
Mood disorders affect one in four people in their lifetime, researchers noted. Depression in particular is the leading cause of disability for people ages 15-44. Because of a lack of objective tests and perceived stigma, mood disorders are often undiagnosed or misdiagnosed – for example, depression instead of bipolar disorder.
Additionally, patients with these conditions often do not receive adequate care, and can turn to self-medication with alcohol and drugs....
Today's Sponsors
Today's Sponsor